Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $12,174 - $13,745
-53 Reduced 4.88%
1,032 $255,000
Q4 2022

Feb 09, 2023

BUY
$218.29 - $256.91 $32,743 - $38,536
150 Added 16.04%
1,085 $276,000
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $47,713 - $247,055
935 New
935 $208,000
Q1 2020

May 12, 2020

SELL
$195.69 - $279.01 $277,879 - $396,194
-1,420 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$236.45 - $266.82 $116,096 - $131,008
-491 Reduced 25.69%
1,420 $386,000
Q3 2019

Nov 15, 2019

BUY
$230.58 - $256.08 $13,373 - $14,852
58 Added 3.13%
1,911 $484,000
Q2 2019

Aug 09, 2019

SELL
$217.4 - $246.08 $78,264 - $88,588
-360 Reduced 16.27%
1,853 $467,000
Q1 2019

May 16, 2019

SELL
$206.05 - $248.17 $572,200 - $689,168
-2,777 Reduced 55.65%
2,213 $553,000
Q4 2018

Feb 06, 2019

BUY
$204.73 - $257.93 $1.02 Million - $1.29 Million
4,990 New
4,990 $1.12 Million
Q3 2018

Nov 13, 2018

SELL
$233.07 - $256.0 $1.24 Million - $1.36 Million
-5,318 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$208.1 - $233.85 $683,608 - $768,197
3,285 Added 161.58%
5,318 $1.27 Million
Q1 2018

Apr 16, 2018

SELL
$205.46 - $240.27 $67,801 - $79,289
-330 Reduced 13.97%
2,033 $441,000
Q1 2018

Apr 16, 2018

BUY
$205.46 - $240.27 $96,360 - $112,686
469 Added 24.76%
2,363 $433,000
Q4 2017

Feb 16, 2018

SELL
$189.0 - $222.64 $77,112 - $90,837
-408 Reduced 17.72%
1,894 $405,000
Q3 2017

Nov 20, 2017

BUY
$186.89 - $198.9 $18,315 - $19,492
98 Added 4.45%
2,302 $451,000
Q2 2017

Aug 16, 2017

BUY
N/A
2,204
2,204 $430,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Wealthsource Partners, LLC Portfolio

Follow Wealthsource Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthsource Partners, LLC with notifications on news.